Psyence Biomedical (PBM) Receivables - Other (2023 - 2026)
Psyence Biomedical's (PBM) quarterly Receivables - Other came in at $109779.0 in Q1 2026, down 20.07% year-on-year from $137348.0 in Q1 2025, and down 36.98% quarter-over-quarter from $174187.0 in Q3 2025.
Psyence Biomedical (PBM) Receivables - Other (2023 - 2026) Analysis & Trends
Psyence Biomedical's Receivables - Other history runs 4 years deep, the most recent figure standing at $109779.0 for Q1 2026.
- On a quarterly basis, Receivables - Other fell 20.07% year-over-year to $109779.0 in Q1 2026; TTM through Mar 2026 was $109779.0, a 20.07% decrease from a year earlier, with the FY2026 full-year figure at $109779.0, down 20.07% from the prior year.
- Receivables - Other declined to $109779.0 in Q1 2026 per PBM's latest filing, from $174187.0 in the prior quarter.
- Across five years, Receivables - Other topped out at $174187.0 in Q3 2025 and bottomed at $41747.0 in Q1 2024.
- The 4-year median for Receivables - Other is $131214.0 (2024), against an average of $122918.3.
- Across the five-year window, Receivables - Other slumped 72.05% in 2024 and surged 229.0% in 2025, its largest moves.
- Year by year, Receivables - Other stood at $149369.0 in 2023, then dropped by 16.26% to $125080.0 in 2024, then jumped by 39.26% to $174187.0 in 2025, then slumped by 36.98% to $109779.0 in 2026.
- Per Business Quant, the three latest PBM Receivables - Other figures stand at $109779.0 (Q1 2026), $174187.0 (Q3 2025), and $137348.0 (Q1 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Psyence Biomedical | 1.56 Mn | 1.56 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 109,779.00 |
| Mar 31, 2026 | 109,779.00 |
| Sep 30, 2025 | 174,187.00 |
| Sep 30, 2025 | 174,187.00 |
| Mar 31, 2025 | 137,348.00 |
| Mar 31, 2025 | 137,348.00 |
| Sep 30, 2024 | 125,080.00 |
| Sep 30, 2024 | 125,080.00 |
| Mar 31, 2024 | 41,747.00 |
| Mar 31, 2024 | 41,747.00 |
| Mar 31, 2023 | 149,369.00 |
| Mar 31, 2023 | 149,369.00 |